Travere Therapeutics Inc
TVTX
$52.79-0.90%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$1.33B
EV/Sales
2.53
P/E ratio
N/A
FY2025 Revenue
$490.73M
EPS (TTM)
$-0.46
Gross Margin (FY2025)
97.89%
Profit Margin (FY2025)
-5.21%
Beta
0.74
Div yield
N/A
Sector
Healthcare
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported TVTX revenue for 2025-12-31 was $490.7M. Net income was -$25.5M. Revenue was up 110.5% from 2024-12-31 to 2025-12-31. TVTX currently screens at market cap $1.33B.
Use this TVTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TVTX income, balance, and cash tables.
Travere Therapeutics Inc (TVTX) is a biotechnology company in the Healthcare sector.
Latest cached Travere Therapeutics Inc (TVTX) revenue for Dec 31, 2025 was $490.7M. Net income was -$25.5M. Statements: https://lician.com/financials/tvtx
Travere Therapeutics Inc (TVTX) market capitalization is $1.33B on the latest cached snapshot.
Travere Therapeutics Inc (TVTX) cached previous close $53.27; day range $52.79 – $53.94; volume 1,876,639. Session quote: https://lician.com/quote/tvtx
Travere Therapeutics Inc (TVTX) latest cached earnings event is "TVTX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TVTX filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/tvtx